Moisand Fitzgerald Tamayo, LLC Viatris Inc Transaction History

Moisand Fitzgerald Tamayo, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$8.77 - $10.85 $78 - $97	-9 Reduced 1.08%	828 $8,000
Q3 2023 Oct 20, 2023	BUY	$9.59 - $11.35 $172 - $204	18 Added 2.2%	837 $8,000
Q1 2023 May 05, 2023	BUY	$9.2 - $12.26 $174 - $232	19 Added 2.38%	819 $7,000
Q2 2022 Aug 01, 2022	BUY	$9.95 - $12.27 $7,959 - $9,816	800 New	800 $8,000
Q1 2022 Apr 29, 2022	SELL	$9.81 - $15.4 $7,848 - $12,320	-800 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$12.97 - $16.15 $194 - $242	-15 Reduced 1.84%	800 $11,000
Q1 2021 May 03, 2021	SELL	$13.59 - $18.54 $3,424 - $4,672	-252 Reduced 23.62%	815 $11,000
Q4 2020 Feb 02, 2021	BUY	$14.3 - $18.74 $15,258 - $19,995	1,067 New	1,067 $20,000

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.